Skip to main content
Premium Trial:

Request an Annual Quote

DNA Script Gets $1.6M From French Government to Develop qPCR Probe Manufacturing Platform

NEW YORK — Nucleic acid manufacturer DNA Script said on Thursday that it has received $1.6 million from the French Defense Innovation Agency to build a prototype qPCR probe manufacturing platform that can be used in the rapid development of biothreat diagnostics.

DNA Script said it will adapt its Syntax benchtop DNA printer for the rapid synthesis of DNA reagents such as Taqman probes that can be used to develop tests for the detection of pathogenic viruses and bacteria. The prototype will then be evaluated by the French Armament General Directorate.

"We are thrilled to collaborate with the French Ministry for Armed Forces on this important initiative to rapidly detect, characterize, and mitigate threats from newly emerging or engineered pathogens," DNA Script CEO Thomas Ybert said in a statement.

In mid-2020, Paris-based DNA Script extended a Series B financing round to $89 million.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.